THE BUSINESS OF LONGEVITY

Chapter Two

The Chairman

Reconstructing the Corporate History of Max Lewinsohn

Introduction

Every successful company has a public face.

Corporate websites highlight experience, achievements and leadership. They introduce the people entrusted with guiding the organisation and reassuring patients, partners and investors that the business is in capable hands.

Wellbeing International Foundation is no different.

At the centre of its leadership team is Chairman Max Lewinsohn.

The company's biography presents him as a Chartered Accountant with more than four decades of international corporate experience, someone who has guided numerous public companies and advised businesses operating across several sectors.

On paper, it is an impressive résumé.

But biographies are, by their very nature, selective.

They tell us what an organisation wishes us to know.

Investigative journalism asks a different question.

What does the public record reveal?

This article is not an allegation of wrongdoing.

Nor is it an attempt to judge a career that spans more than forty years.

Instead, it is an exercise in reconstruction.

Using company records, court judgments, insolvency proceedings and other primary sources, we begin assembling the documented history behind one of the key figures leading Wellbeing International Foundation.

Why Leadership Matters

Every investor studies management.

Every lender examines directors.

Every shareholder wants to know who is responsible for protecting their investment.

Healthcare is no different.

Patients may focus on treatments and clinical outcomes, but behind every organisation are individuals making strategic decisions about finance, expansion, governance and investment.

Those decisions shape the future of the company every bit as much as the science itself.

When a business asks patients to place their trust in an emerging therapy—and asks investors to provide capital for future growth—it is entirely reasonable to examine the experience of those leading the organisation.

The Public Biography

Wellbeing describes Max Lewinsohn as an experienced Chartered Accountant with more than forty years of international business experience.

The published biography refers to his involvement with numerous listed companies and highlights previous board positions in finance, investment and technology.

Taken at face value, it portrays a businessman with substantial corporate experience and a long history of advising growing enterprises.

There is nothing unusual about that.

Many biotechnology businesses deliberately recruit experienced financiers and commercial strategists to help transform scientific innovation into sustainable companies.

But biographies rarely tell the complete story.

Looking Beyond the Biography

As this investigation progressed, another picture began to emerge.

Publicly available records show connections with businesses spanning several decades, across different industries and jurisdictions.

Some of those businesses were successful.

Others encountered significant financial difficulties.

Several became involved in insolvency proceedings.

Some generated litigation.

Corporate failure is not, in itself, evidence of misconduct.

Many respected entrepreneurs have experienced bankruptcies, restructurings or unsuccessful ventures before building successful businesses.

Equally, previous corporate history forms an important part of understanding any business leader's experience.

It deserves examination rather than assumption.

Dominion International

One of the earliest companies associated with Max Lewinsohn was Dominion International.

Contemporary reporting described Dominion as a financial-services and property group that ultimately collapsed.

Published reports also indicate that proceedings were later brought under the Company Directors Disqualification Act in connection with the company's failure.

At the time of writing, this investigation is obtaining the original court papers, insolvency reports and regulatory documents to establish precisely:

• Mr Lewinsohn's role;

• the findings of the court;

• the reasons for any reported disqualification;

• the financial outcome for creditors and investors.

Until those primary documents have been reviewed, it would be inappropriate to draw conclusions beyond what has been publicly recorded.

The original records—not newspaper summaries—will form the basis of the next stage of this investigation.

Eneco

A decade later, Max Lewinsohn's name again appears within extensive court records relating to Eneco Inc., an American technology company attempting to commercialise energy-related intellectual property.

Court documents describe the company's financial difficulties, subsequent Chapter 11 bankruptcy and eventual liquidation.

They also describe Mr Lewinsohn's involvement through Maximillian & Co. and the complex legal disputes that followed concerning intellectual-property ownership after the bankruptcy.

Those proceedings extended over several years and generated substantial litigation.

As with Dominion, the existence of litigation does not determine liability or wrongdoing.

The importance lies in understanding the documented facts rather than relying upon assumption.

This investigation is now reconstructing those proceedings directly from the judgments themselves.

Recent Corporate Activity

Public records also connect Mr Lewinsohn with more recent companies that have entered creditors' voluntary liquidation.

Again, liquidation alone is not unusual in business.

Companies fail for many reasons.

The important questions are factual ones.

When was he appointed?

What role did he hold?

What financial condition was the company in?

What conclusions, if any, did the liquidators reach regarding director conduct?

Those answers will come not from commentary, but from official filings.

Why This Matters Today

None of this history automatically predicts the future.

Past corporate failures do not prevent individuals from leading successful businesses later in life.

Nor do they establish any connection with Wellbeing International Foundation.

However, history provides context.

When a private company seeks investment while operating in an emerging area of medicine, prospective investors may reasonably wish to understand the experience of those leading the organisation.

Likewise, patients placing trust in an innovative healthcare provider are entitled to know who sits at the top of the business.

Transparency strengthens confidence.

It does not weaken it.

Where the Investigation Goes Next

This chapter is intentionally incomplete.

Not because the evidence is lacking.

But because the investigation has only just begun.

Over the coming weeks, this series will examine:

• original Companies House records;

• court judgments;

• insolvency reports;

• director appointments;

• corporate restructurings;

• public statements made over time.

The objective is not to build a case for or against any individual.

It is to replace speculation with documentation.

Only then can readers judge the record for themselves.

Because in business, as in science, the strongest evidence is always found in the original documents—not the headlines.